Genomic Test Helps Decide Which DCIS Needs Radiation

The Oncotype DX Breast DCIS Score test is used to help people and their doctors make decisions about whether radiation after lumpectomy surgery to remove DCIS would offer more benefits than risks. At the 2023 San Antonio Breast Cancer Symposium, Dr. Seema Khan presented results from the E4112 study, evaluating the ability of the Oncotype DX Breast DCIS Score to accurately predict which women would benefit from radiation after DCIS surgery and which women could safely skip radiation. Listen to the podcast to hear Dr. Khan explain: the design of the study, including why a prospective study is important the results how the results fit into the current context of DCIS care

Om Podcasten

Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Our mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer, so they can make the best decisions for their lives. Breastcancer.org podcasts offer unique insights on prevention, treatment, research, and other breast cancer topics from our medical experts and invited guests.